Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
Gori A, Trabattoni D, Bandera A, Saresella M, Marchetti G, Gazzola L, Biasin M, Rhodes J, McDade H, Panebianco R, Galli M, Moroni M, Ferrante P, Thomas N, Franzetti F, Bray D, Clerici M.
Gori A, et al. Among authors: bandera a.
Antivir Ther. 2004 Aug;9(4):603-14.
Antivir Ther. 2004.
PMID: 15456092
Clinical Trial.